US$ 20.75
glp 1 receptor agonists weight loss GLP-1 drugs leave users low on key nutrients, study finds Beyond Weight Loss: Other Benefits
Description
2024;7(8):e2423385
Association of bile duct and gallbladder diseases with the use of Incretin-based drugs in patients with type 2 diabetes mellitus
doi: 10.1016/j.phrs.2022.106550 24 SalcedoITweedieDLiYGreigNH

Thats good, but not transformative

34 The most common cause of glucosuria is T2DM, and the average patient will not spill glucose into their urine until his or her blood glucose concentration exceeds approximately 180 mg/dL

Both Tirzepatide and Semaglutide (Ozempic) are once-weekly injections for the treatment of diabetes and obesity
